FDA Clearance Tracker · P000025-S006
MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM WITH C40+, C40+S, OR C40+GB IMPLANTS, AND CIS PRP+/TEMPO+ SPEECH PROCESSORS
Last checked: Nov 20, 2026Latest source record: Mar 18, 2003 (this decision)Source: openFDAMethods & limitations
Decided
Mar 18, 2003
Approved
Time to decision
137 days
Received Nov 1, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P000025-S006
- Device name
- MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM WITH C40+, C40+S, OR C40+GB IMPLANTS, AND CIS PRP+/TEMPO+ SPEECH PROCESSORS
- Applicant
- Med-El Corp.
- Applicant location
- Innsbruck
- Received
- Nov 1, 2002
- Decided
- Mar 18, 2003
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P000025
Device type
- Device type
- Implant, cochlear (MCM)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
APPROVAL FOR BROADENING THE INDICATION OF THE C40+ COCHLEAR IMPLANT SYSTEM TO INCLUDE CHILDREN AGED TWELVE MONTHS OR OLDER.
Source documents
Other decisions for Med-El Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MED-EL CI SystemPMA supplement
P000025-S134 · Decided Nov 26, 2025 · 287 days after receipt · Panel Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.